Results 11 to 20 of about 2,535,326 (289)
Investigating the impact of NHS based ovarian cancer screening [PDF]
the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006.
Nicholson, S. M.
core +7 more sources
Investigating the potential for expediting diagnosis of ovarian cancer via prompt symptom recognition & "targeted screening" [PDF]
PhDThis thesis explores the potential for using symptoms as a tool to bring forward the diagnosis of ovarian cancer. Current evidence supports the existence of prediagnostic symptoms, however symptom lead time has yet to be adequately quantified ...
Lim, Anita Wey Wey
core +4 more sources
Performance of Ovarian Response Prediction Index As Predictor of Ovarian Response
Objective: We aimed to evaluate potential predictors of response to controlled ovarian stimulation (COS), including follicle stimulating hormone (FSH), Estradiol, antral follicle count (AFC), and ovarian response prediction index (ORPI). Methods: In this
Bolormaa Dagvadorj +5 more
doaj +1 more source
Ovarian Biomechanics: From Health to Disease
Biomechanics is a physical phenomenon which mainly related with deformation and movement of life forms. As a mechanical signal, it participates in the growth and development of many tissues and organs, including ovary.
Chenchen Sun +4 more
doaj +1 more source
RUNX1-Regulated Signaling Pathways in Ovarian Cancer
Ovarian cancer is the leading cause of gynecological death worldwide, and its poor prognosis and high mortality seriously affect the life of ovarian cancer patients.
Yuanzhi Chen, Yingying He, Shubai Liu
doaj +1 more source
Objective: Apolipoprotein A1 (ApoA1) is remarkably decreased in serum and ovarian tissues of ovarian cancer patients. ApoA1 and ApoA1 mimetic peptides can sequestrate pro-inflammatory phospholipids, some of which are known to activate a variety of ...
Aline T. Marinho +8 more
doaj +1 more source
Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Kirschenhofer, Angela +9 more
core +1 more source
Paraneoplastic thrombocytosis in ovarian cancer [PDF]
<p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Han, H.D. +33 more
core +1 more source
Polyamines in Ovarian Aging and Disease
Ovarian aging and disease-related decline in fertility are challenging medical and economic issues with an increasing prevalence. Polyamines are a class of polycationic alkylamines widely distributed in mammals. They are small molecules essential for cell growth and development.
Bo Kang +7 more
openaire +2 more sources

